Provectus Biopharmaceuticals Inc (OTCQB:PVCT)

0.0745
Delayed Data
As of 10:38am ET
 +0.0025 / +3.47%
Today’s Change
0.02
Today|||52-Week Range
0.09
-9.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization679.7K684.3K684.2K687.0K
 
 
 
 
 
 
Operating ExpensesGross Income-679.7K-684.3K-684.2K-687.0K
 
 
 
 
 
General Expenses16.1M24.0M23.8M13.0M
 
 
 
 
 
Research And Development5.1M10.7M7.9M7.5M
 
 
 
 
 
Total Operating Expenses16.8M24.7M24.5M13.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.8M-24.7M-24.5M-13.7M
 
 
 
 
 
Extraordinary Credit6.6M146.6K518.9K20.0K
 
 
 
 
 
Extraordinary Charge0.000.00-436.2K0.00
 
 
Other Expenses0.000.000.00152.4K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-24.5M-24.4M-13.5M
 
 
 
 
 
Preferred Dividend0.000.00-4.4M-14.1K
 
 
 
Net Income-10.2M-24.5M-24.4M-13.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS175.8M195.7M233.8M369.2M
 
 
 
 
 
Shares To Calculate EPS Diluted175.8M195.7M233.8M369.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.13-$0.12-$0.04
 
 
 
 
 
EPS Diluted-$0.06-$0.13-$0.12-$0.04